Very important message written by my chair Aron Popovtzer and oncology colleagues in Israel. Thank you all for your support 🙏🙏

Daniel Levi Ludmir, un médico asesinado en Israel. BDE.

A hero that was murdered for saving others 💔

Daniel Levi, from Peru, lived in a Kibbutz in the south of Israel.

Hamas terrorists invaded the community where he lived with his family and began slaughtering dozens of people.

Daniel, who was a doctor, insisted that his family…

Thank you Laura Dawson and Radiation Oncology for the statement of support that clearly and plainly identifies this as a terrorist attack by Hamas; not sure why Temerty Medicine felt they had to 'both sides' it.

Now let the snivelling apologists for rape, murder and torture explain how this, too, was justified.

You know me, I’m generally a positive person. But the way this will play out? Not so sure I see this ending in a positive way. Here’s how I see it playing out.

Before I get into it, I will just say that according to Jewish scripture, before Mashiach comes, there will be a huge…

Outstanding work from C. Jillian Tsai, MD, PhD Michael Yang, MD MSc FRCSC and the PROP team Radiation Medicine Program; insights into design, endpoints, and interpretation of oligo trials! Part of a dedicated Seminars Rad Onc issue on clinical trial advances Radiation Oncology | Dartmouth Cancer Center MD Anderson Cancer Center

Findings from a new MD Anderson Cancer Center study strongly argue for greater resource allocation and funding mechanisms for local therapy clinical trials.

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Alexander Sherry, MD Kelsey Corrigan MD MPH Ramez Kouzy, MD Joseph Abi Jaoude Fuller Lab Ethan Ludmir MD

CC: Vivek Subbiah, MD, OncoAlert

Tremendous thanks to Cholangiocarcinoma Foundation for their generous support, and the mentorship of Eugene J. Koay, MD, PhD Milind Javle & the team MD Anderson Cancer Center; it’s a privilege to help care for #cholangiocarcinoma patients, who are among the most inspiring folks you will ever meet. #cureCCA #CCAhope

Thanks for your amazing support Emma B. Holliday MD and to the organizers at ARS for a great meeting.
Want to learn more about the current state of PH3 oncology and what questions are being tested?
Check out our study in ACS Journal Cancer & read on for a brief 🧵
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Lots of fun bowling with the GI rad onc team! Our physics, nursing, clinical research, and admin colleagues all joined us! Emma B. Holliday MD Eugene J. Koay, MD, PhD Ethan Ludmir MD Cullen Taniguchi, MD Sonal Noticewala, MD, MAS MD Anderson Cancer Center

Instead of analyzing progression-free survival and overall-survival separately, using a single endpoint that combines these outcomes may result in a clinically meaningful and more efficient summary estimate of treatment effect in comparative trials. ja.ma/43PZZDH

📢 Constance Owens, PhD MedPhys Graduate Program MD Anderson UT Health PhD student MD Anderson-UTH Grad

Giving a PLENARY presentation on RT-related colorectal cancer at the Childhood Cancer Survivor Study Annual Meeting

I am so very proud of this accomplishment ‼️

#radonc faculty photo ⁦MD Anderson Cancer Center⁩. I am privileged to work with such a great group of dedicated faculty who deliver excellence in clinical care, research, and education everyday. #endcancer #gratitude ⁦Peter WT Pisters, MD⁩

A study led by our Dr. Ethan Ludmir shows that primary endpoints of Phase III cancer clinical trials frequently change. Learn about his research here: fal.cn/3ymL3 Healio HemOnc Today @EBLudmir #EndCancer

Excited to share our work on the incidence of PEP changes in phase 3 clinical trials. I'm grateful for the opportunity to work on such an impactful project under the mentorship of Ethan Ludmir MD and Joseph Abi Jaoude. Thnx to the support of our team MD Anderson Cancer Center jamanetwork.com/journals/jaman…

Outstanding work by the incredible Summer(Yumeng) Yang! Applying NLP to improve access and accrual for cancer trials holds incredible promise, and a pleasure to learn from Kirk Roberts! An education in informatics!! 𝖉𝖆𝖛𝖊 𝖋𝖚𝖑𝖑𝖊𝖗 @[email protected] AmyMorenoMD

PRIME II update (nejm.org/doi/full/10.10…) confirms #radiotherapy confers 90% ⬇️ LRR in older women with low-risk #breastcancer . EUROPA (clinicaltrials.gov/ct2/show/NCT04…) is asking the more important question. Can we give five DAYS of #APBI instead of five YEARS of endocrine therapy? #bcsm

Stop by to see our poster on the evolution of the immune microenvironment of #kidneycancer treated with radiation therapy. Translational work providing biological insights led by #KiekoHara and Chad Tang, MD. #GU23

Terrific work by Jillian Gunther Prajnan Das, MD, MS, MPH MD Anderson Cancer Center
Solid randomized data are key in this space! (academic.oup.com/jnci/article/1…)